drugset / Trial / NCT00152984

Efficacy and Safety of Tiotropium in Patients With COPD and Concomitant Diagnosis of Asthma

NCT00152984

Phase 4 Completed 472 enrolled Boehringer Ingelheim
RandomizedParallel-groupDouble-blindTreatment

Summary

The primary objective of this study is to demonstrate the superiority of tiotropium compared to placebo in the treatment of patients with COPD and a concomitant diagnosis of asthma

Timeline

Start
2004-12
Primary completion
2006-04
Completion
2006-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Tiotropium Other / unclassified 18 ug Inhaled